Suppr超能文献

通过阻断 nikkomycin X 的咪唑酮生物合成途径和 Streptomyces ansochromogenes 中尿嘧啶的进料来选择性地提高 nikkomycin Z 的产量。

Selectively improving nikkomycin Z production by blocking the imidazolone biosynthetic pathway of nikkomycin X and uracil feeding in Streptomyces ansochromogenes.

机构信息

State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, PR China.

出版信息

Microb Cell Fact. 2009 Nov 23;8:61. doi: 10.1186/1475-2859-8-61.

Abstract

BACKGROUND

Nikkomycins are a group of peptidyl nucleoside antibiotics and act as potent inhibitors of chitin synthases in fungi and insects. Nikkomycin X and Z are the main components produced by Streptomyces ansochromogenes. Of them, nikkomycin Z is a promising antifungal agent with clinical significance. Since highly structural similarities between nikkomycin Z and X, separation of nikkomycin Z from the culture medium of S. ansochromogenes is difficult. Thus, generating a nikkomycin Z selectively producing strain is vital to scale up the nikkomycin Z yields for clinical trials.

RESULTS

A nikkomycin Z producing strain (sanPDM) was constructed by blocking the imidazolone biosynthetic pathway of nikkomycin X via genetic manipulation and yielded 300 mg/L nikkomycin Z and abolished the nikkomycin X production. To further increase the yield of nikkomycin Z, the effects of different precursors on its production were investigated. Precursors of nucleoside moiety (uracil or uridine) had a stimulatory effect on nikkomycin Z production while precursors of peptidyl moiety (L-lysine and L-glutamate) had no effect. sanPDM produced the maximum yields of nikkomycin Z (800 mg/L) in the presence of uracil at the concentration of 2 g/L and it was approximately 2.6-fold higher than that of the parent strain.

CONCLUSION

A high nikkomycin Z selectively producing was obtained by genetic manipulation combined with precursors feeding. The strategy presented here might be applicable in other bacteria to selectively produce targeted antibiotics.

摘要

背景

尼克霉素是一组肽核苷抗生素,作为真菌和昆虫几丁质合成酶的有效抑制剂。尼克霉素 X 和 Z 是变红红链霉菌产生的主要成分。其中,尼克霉素 Z 是一种具有临床意义的有前途的抗真菌药物。由于尼克霉素 Z 和 X 之间具有高度的结构相似性,因此从变红红链霉菌的培养基中分离尼克霉素 Z 非常困难。因此,产生尼克霉素 Z 选择性生产菌株对于扩大临床试验用尼克霉素 Z 的产量至关重要。

结果

通过遗传操作阻断尼克霉素 X 的咪唑啉生物合成途径,构建了一种尼克霉素 Z 产生菌株(sanPDM),该菌株产生 300mg/L 的尼克霉素 Z,同时消除了尼克霉素 X 的产生。为了进一步提高尼克霉素 Z 的产量,研究了不同前体对其产生的影响。核苷部分的前体(尿嘧啶或尿苷)对尼克霉素 Z 的产生有刺激作用,而肽部分的前体(L-赖氨酸和 L-谷氨酸)没有影响。在 2g/L 尿嘧啶存在的情况下,sanPDM 产生的尼克霉素 Z 最大产量(800mg/L)约为亲本菌株的 2.6 倍。

结论

通过遗传操作结合前体喂养获得了高选择性生产尼克霉素 Z 的菌株。本研究提出的策略可能适用于其他细菌,以选择性地生产目标抗生素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11b/2787493/d2f9df9e76fa/1475-2859-8-61-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验